This inventor holds 1 USPTO granted patent. Top assignee: Teva Biopharmaceuticals USA, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Qinghai Zhao in Biopharmaceuticals
Introduction
Qinghai Zhao is a notable inventor based in Gaithersburg, MA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of fusion proteins that enhance insulin activity.
Latest Patents
Qinghai Zhao holds a patent for "Albumin-insulin fusion proteins." This patent discloses fusion proteins that include albumin fused to a polypeptide with insulin activity. The fusion proteins may consist of albumin fused to insulin or an insulin analog. Notably, these fusion proteins may exhibit extended insulin activity in vivo or in vitro compared to insulin that is not fused to albumin. Additionally, the fusion proteins can be formulated as aerosol compositions.
Career Highlights
Qinghai Zhao is currently employed at Teva Biopharmaceuticals USA, Inc. His work focuses on innovative solutions in the biopharmaceutical sector, contributing to advancements in diabetes treatment through his patented technologies.
Collaborations
Qinghai Zhao has collaborated with notable colleagues, including Adam C Bell and Craig A Rosen. These collaborations have likely enhanced the research and development efforts within his field.
Conclusion
Qinghai Zhao's work in developing albumin-insulin fusion proteins represents a significant advancement in biopharmaceuticals. His contributions are poised to impact the treatment of diabetes and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile